These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17251541)

  • 21. [Facilitating nursing at home and in the nursing home].
    Krankenpfl J; 2005; 43(1-3):34-5. PubMed ID: 15912827
    [No Abstract]   [Full Text] [Related]  

  • 22. Dementia and antipsychotic drugs.
    Raskind MA; Risse SC; Lampe TH
    J Clin Psychiatry; 1987 May; 48 Suppl():16-8. PubMed ID: 2883175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacotherapy of neuropsychiatric symptoms: opportunities, challenges and current prospects.
    Rabins PV; Lyketsos CG
    Nat Clin Pract Neurol; 2007 May; 3(5):239. PubMed ID: 17479071
    [No Abstract]   [Full Text] [Related]  

  • 24. Risperidone in the treatment of elderly patients with psychosis of Alzheimer's disease and related dementias.
    Grossman F; Okamoto A; Turkoz I; Gharabawi G
    J Am Geriatr Soc; 2004 May; 52(5):852-3. PubMed ID: 15086685
    [No Abstract]   [Full Text] [Related]  

  • 25. Re: Chan et al. A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients. Int J Geriatr Psychiatry 16: 1156 - 1162.
    Onalaja D; Jainer AK
    Int J Geriatr Psychiatry; 2002 Nov; 17(11):1076-7; author reply 1077. PubMed ID: 12404659
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of behavioral disorders in dementia with risperidone in psychogeriatric out-patients].
    Kurz A; Delius-Stute H; Rettig K; Schwalen S
    MMW Fortschr Med; 2003 Oct; 145 Suppl 3():89-95. PubMed ID: 15490773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroleptic drugs in dementia: benefits and harm.
    Ballard C; Howard R
    Nat Rev Neurosci; 2006 Jun; 7(6):492-500. PubMed ID: 16715057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tolerance of bromperidol in long term application].
    Scelovic B
    Int Pharmacopsychiatry; 1978; 13 Suppl 1():38-40. PubMed ID: 35477
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of behavioral disorders in dementia with risperidone in psychogeriatric outpatients].
    Kurz A; Delius-Stute H; Rettig K; Schwalen S
    MMW Fortschr Med; 2003 Oct; 145(42):55. PubMed ID: 14655446
    [No Abstract]   [Full Text] [Related]  

  • 30. [Risperidone in the ambulatory treatment of behavior disorders in demented patients of Alzheimer's type: a retrospective analysis].
    Sobów TM; Kłoszewska I
    Psychiatr Pol; 2001; 35(6):1033-45. PubMed ID: 11877883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risperidone and dementia-related aggression: new indication. A last resort, no better than haloperidol.
    Prescrire Int; 2009 Dec; 18(104):248. PubMed ID: 20025088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developing treatment guidelines for Alzheimer's disease and other dementias.
    Rabins PV
    J Clin Psychiatry; 1996; 57 Suppl 14():37-8. PubMed ID: 9024335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbamazepine treatment of agitation in Alzheimer's outpatients refractory to neuroleptics.
    Gleason RP; Schneider LS
    J Clin Psychiatry; 1990 Mar; 51(3):115-8. PubMed ID: 1968457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New Alzheimer's clinical trials to be undertaken by NIA nationwide consortium.
    Am J Alzheimers Dis Other Demen; 2006 Dec-2007 Jan; 21(6):460-1. PubMed ID: 17288014
    [No Abstract]   [Full Text] [Related]  

  • 35. Behavioral effects of current Alzheimer's disease treatments: a descriptive review.
    Cummings JL; Mackell J; Kaufer D
    Alzheimers Dement; 2008 Jan; 4(1):49-60. PubMed ID: 18631950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Alzheimer's disease.
    De Deyn PP
    N Engl J Med; 2000 Mar; 342(11):821; author reply 821-2. PubMed ID: 10722341
    [No Abstract]   [Full Text] [Related]  

  • 37. [Study methods of drugs in Alzheimer disease].
    Dubois B; Stehlé B; Lehner JP; Derouesné C; Bourin M; Lamour Y; Blin O; Jourdain G; Alperovitch A
    Therapie; 1996; 51(4):444-8. PubMed ID: 8953828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychosis-related disturbances. Psychosis, agitation, and disinhibition in Alzheimer's disease: definitions and treatment options.
    Lesser JM; Hughes S
    Geriatrics; 2006 Dec; 61(12):14-20. PubMed ID: 17184138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer's disease and its effect on handwriting.
    Behrendt JE
    J Forensic Sci; 1984 Jan; 29(1):87-91. PubMed ID: 6142081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amisulpride in the treatment of behavioural disturbances among patients with moderate to severe Alzheimer's disease.
    Mauri M; Mancioli A; Rebecchi V; Corbetta S; Colombo C; Bono G
    Acta Neurol Scand; 2006 Aug; 114(2):97-101. PubMed ID: 16867031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.